24.3.23 Rua Bioscience is to cease local GMP manufacturing and accelerate its global brand strategy and building its export product pipeline. . Working with manufacturing partners, Rua expects New Zealand patients will ultimately benefit from a wider range of affordable medicines. CEO, Paul Naske, says Rua has been actively exploring where true value lies in […]